Effects of risperidone and haloperidol on tachykinin and opioid precursor peptide mRNA levels in the caudate-putamen and nucleus accumbens of the rat

Synapse

Volumn 28, Issue 4, 1998, Pages 302-312

  Mijnster, M Janneke ^a   Schotte, Alain ^b   Docter, Gerrit J ^a   Voorn, Pieter ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

Antipsychotic drugs; Dynorphin; Enkephalin; In situ hybridization; Striatum; Substance P

Indexed keywords

DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; MESSENGER RNA; NEUROLEPTIC AGENT; OPIATE PEPTIDE; PREPROENKEPHALIN; PREPROTACHYKININ; RISPERIDONE; RITANSERIN; SEROTONIN 2A ANTAGONIST; TACHYKININ;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; HORMONE DETERMINATION; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PUTAMEN; RAT; RNA ANALYSIS;

ANIMALS; ANTIPSYCHOTIC AGENTS; CAUDATE NUCLEUS; CORPUS STRIATUM; ENKEPHALINS; HALOPERIDOL; MALE; NUCLEUS ACCUMBENS; PROTEIN PRECURSORS; PUTAMEN; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; RECEPTORS, SEROTONIN; RISPERIDONE; RITANSERIN; RNA, MESSENGER; TACHYKININS;

EID: 0031892409     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199804)28:4<302::AID-SYN6>3.0.CO;2-D     Document Type: Article

References (55)

1. Anderson, K.D., and Reiner, A. (1990) Extensive co-occurrence of substance P and dynorphin in striatal projection neurons: An evolutionary conserved feature of basal ganglia organization. J. Comp. Neurol. 295:339-369.
2. Angulo, J.A., Cadet, J.L., and McEwen, B.S. (1990a) Effect of typical and atypical neuroleptic treatment on protachykinin mRNA levels in the striatum of the rat. Neurosci. Lett., 113:217-221.
3. Angulo, J.A., Cadet, J.L., Woolley, C.S., Suber, F., and McEwen, B.S. (1990b) Effect of chronic typical and atypical neuroleptic treatment on proenkephalin mRNA levels in the striatum and nucleus accumbens of the rat. J. Neurochem. 54:1889-1894.
4. Augood, S.J., Westmore, K., Faull, R.L., and Emson, P.C. (1993) Neuroleptics and striatal neuropeptide gene expression. Prog. Brain Res. 99:181-199.
5. Bannon, M.J., Elliott, P.J., and Bunney, E.B. (1987) Striatal tachykinin biosynthesis: Regulation of mRNA and peptide levels by dopamine agonists and antagonists. Brain Res. 427:31-37.
6. Bardo, M.T., and Hammer, R.P., Jr. (1991) Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions. Neuroscience, 45:281-290.
7. Bersani, G., Grispini, A., Marini, S., Pasini, A., Valducci, M., and Ciani, N. (1990) 5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: A double-blind comparison with orphenadrine and placebo. Clin. Neuropharmacol., 13:500-506.
8. Borison, R.L., Pathiraja, A.P., Diamond, B.L., and Meibach, R.C. (1992) Risperidone: Clinical safety and efficacy in schizophrenia. Psychopharmacol. Bull. 28:213-218.
9. Caboche, J., Vernier, P., Rogard, M., and Besson, M.J. (1993) Haloperidol increases PPE mRNA levels in the caudal part of the nucleus accumbens in the rat. Neuroreport, 4:551-554.
10. Chouinard, G., Jones, B., Remington, G., Bloom, D., Addington, D., MacEwan, G.W., Labelle, A., Beauclair, L., and Arnott, W. (1993) A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J. Clin. Psychopharmacol. 13:25-40.
11. Civelli, O., Douglass, J., Goldstein, A., and Herbert, E. (1985) Sequence and expression of the rat prodynorphin gene. Proc. Natl. Acad. Sci. U.S.A., 82:4291-4295.
12. Claus, A., Bollen, J., De Cuyper, H., Eneman, M., Malfroid, M., Peuskens, J., and Heylen, S. (1992) Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: A multicentre double-blind comparative study. Acta Psychiatr. Scand. 85:295-305.
13. Dacko, S., and Schneider, J.S. (1991) Met-enkephalin immunoreactivity in the basal ganglia in symptomatic and asymptomatic MPTP-exposed monkeys: Correlation with degree of parkinsonian symptoms. Neurosci. Lett., 127:49-52.
14. DeLong, M.R. (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci., 13:281-285.
15. Deutch, A.Y. (1993) Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: Implications for schizophrenia and Parkinson's disease. J. Neural Transm. Gen. Sect., 91:197-221.
16. Egan, M.F., Hurd, Y., Hyde, T.M., Weinberger, D.R., Wyatt, R.J., and Kleinman, J.E. (1994) Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias. Synapse, 18:178-189.
17. Egan, M.F., Ferguson, J.N., and Hyde, T.M. (1995) Effects of chronic naloxone administration on vacuous chewing movements and catalepsy in rats treated with long-term haloperidol decanoate. Brain Res. Bull., 38:355-363.
18. Ellenbroek, B., Schwartz, M., Sontag, K.-H., Jaspers, R., and Cools, A. (1985) Muscular rigidity and delineation of a dopamine-specific neostriatal subregion: Tonic EMG activity in rats. Brain Res., 345:132-140.
19. Gerfen, C.R., and Young, W.S., III (1988) Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: An in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460:161-167.
20. Gerfen, C.R., McGinty, J.F., and Young, W.S. (1991) Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: In situ hybridization histochemical analysis. J. Neurosci., 11:1016-1031.
21. Hauber, W., and Schmidt, W.J. (1993) Discrete quinolinic acid lesions of the lateral but not of the medial caudate-putamen reversed haloperidol-induced catalepsy in rats. J. Neural Transm. Gen. Sect., 94:103-114.
22. Herman, Z.S., Huzarska, M., Kmieciak-Kolada, K., and Kowalski, J. (1991) Chronic treatment with chlorpromazine, thioridazine or haloperidol increases striatal enkephalins and their release from rat brain. Psychopharmacology 104:106-112.
23. Hong, J.S., Yang, H.Y., Fratta, W., and Costa, E. (1978) Rat striatal methionine-enkephalin content after chronic treatment with cataleptogenic and noncataleptogenic antischizophrenic drugs. J. Pharmacol. Exp. Ther., 205:141-147.
24. Hong, J.S., Yang, H.Y., Gillin, J.C., and Costa, E. (1980) Effects of long-term administration of antipsychotic drugs on enkephalinergic neurons. Adv. Biochem. Psychopharmacol., 24:223-232.
25. Houdi, A.A., and Van Loon, G.R. (1990) Haloperidol-induced increase in striatal concentration of the tripeptide, Tyr-Gly-Gly, provides an index of increased enkephalin release in vivo. J. Neurochem., 54:1360-1366.
26. Humpel, C., Knaus, G.A., Auer, B., Knaus, H.G., Haring, C., Theodorsson, E., and Saria, A. (1990) Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system. Synapse, 6:1-9.
27. Krause, J.E., Chirgwin, J.M., Carter, M.S., Xu, Z.S., and Hershey, A.D. (1987) Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc. Natl. Acad. Sci. U.S.A., 84:881-885.
28. 2 antagonist. Mol. Pharmacol., 27:600-611.
29. Leysen, J.E., Janssen, P.M., Schotte, A., Luyten, W.H., and Megens, A.A. (1993) Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: Role of 5HT2 receptors. Psychopharmacology 112:S40-S54.
30. Li, S., Sivam, S.P., and Hong, J.S. (1986) Regulation of the concentration of dynorphin A1-8 in the striatonigral pathway by the dopaminergic system. Brain Res., 398:390-392.
31. Li, S.J., Sivam, S.P., McGinty, J.F., Huang, Y.S., and Hong, J.S. (1987) Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway. J. Pharmacol. Exp. Ther., 243:792-798.
32. Lindenmayer, J.P., Gardner, E., Goldberg, E., Opler, L.A., Kay, S.R., van Praag, H.M., Weiner, M., and Zukin, S. (1988) High-dose naloxone in tardive dyskinesia. Psychiatry Res., 26:19-28.
33. Meltzer, H.Y., Matsubara, S., and Lee, J.C. (1989) Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2, and serotonin2 pKi values. J. Pharm. Exp. Ther., 251:238-246.
34. Merchant, K.M., and Dorsa, D.M. (1993) Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics. Proc. Natl. Acad. Sci. U.S.A., 90:3447-3451.
35. Mocchetti, I., Schwartz, J.P., and Costa, E. (1985) Use of mRNA hybridization and radioimmunoassay to study mechanisms of drug-induced accumulation of enkephalins in rat brain structures. Mol. Pharmacol., 28:86-91.
36. Morris, B.J., Hollt, V. and Herz, A. (1988a) Dopaminergic regulation of striatal proenkephalin mRNA and prodynorphin mRNA: Contrasting effects of D1 and D2 antagonists. Neuroscience, 25:525-532.
37. Morris, B.J., Reimer, S., Hollt, V., and Herz, A. (1988b) Regulation of striatal prodynorphin mRNA levels by the raphe-striatal pathway. Brain Res., 464:15-22.
38. Nylander, I. and Terenius, L. (1986) Chronic haloperidol and clozapine differentially affect dynorphin peptides and substance P in basal ganglia of the rat. Brain Res., 380:34-41.
39. Oestreicher, E.G., and Pinto, G.F. (1987) A microcomputer program for fitting enzyme inhibition equations. Comput. Biol. Med., 17:317-321.
40. Paxinos, G., and Watson, C. (1986) The rat brain in stereotaxic coordinates. Sydney: Academic Press.
41. Prinssen, E.P., Ellenbroek, B.A., Stamatovic, B., and Cools, A.R. (1995) Role of striatal dopamine D2 receptors in the paw test, an animal model for the therapeutic efficacy and extrapyramidal side effects of neuroleptic drugs. Brain Res., 673:283-289.
42. Quirion, R., Gaudreau, P., Martel, J.C., St-Pierre, S. and Zamir, N. (1985) Possible interactions between dynorphin and dopaminergic systems in rat basal ganglia and substantia nigra. Brain Res., 331:358-362.
43. Reyntjens, A., Gelders, Y.G., Hoppenbrouwers, M.J.A., and Vanden Bussche, G. (1986) Thymostenic effects of ritanserin (R 55667), a centrally acting serotonin-S2 receptor blocker. Drug Dev. Res., 8:205-211.
44. Roeling, T.A.P., Docter, G.J., Voorn, P., Melchers, B.P.C., Wolters, E.C., and Groenewegen, H.J. (1995) Effects of unilateral 6-hydroxydopamine lesions on neuropeptide immunoreactivity in the basal ganglia of the common marmoset, callithrix jacchus, a quantitative immunohistochemical analysis. J. Chem. Neuroanat., 9:155-164.
45. Schotte, A., Janssen, P.F.M., Gommeren, W., Luyten, W.H.M.L., van Gompel, P., Lesage, A.S., de Loore, K., and Leysen, J.E. (1996) Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding. Psychopharmacology 124: 57-73.
46. Shibata, K., Haverstick, D.M., and Bannon, M.J. (1990) Tachykinin gene expression in rat limbic nuclei: Modulation by dopamine antagonists. J. Pharmacol. Exp. Ther., 255:388-392.
47. Stoessl, A.J., Polanski, E. and Frydryszak, H. (1993) The opiate antagonist naloxone suppresses a rodent model of tardive dyskinesia. Mov. Disord., 8:445-452.
48. Stoof, J.C., Verheijden, P.F., and Leysen, J.E. (1987) Stimulation of D2-receptors in rat nucleus accumbens slices inhibits dopamine and acetylcholine release but not cyclic AMP formation. Brain Res., 423:364-368.
49. Tang, F., Costa, E., and Schwartz, J.P. (1983) Increase of proenkephalin mRNA and enkephalin content of rat striatum after daily injection of haloperidol for 2 to 3 weeks. Proc. Natl. Acad. Sci. U.S.A., 80:3841-3844.
50. Trujillo, K.A., Day, R., and Akil, H. (1990) Regulation of striatonigral prodynorphin peptides by dopaminergic agents. Brain Res., 518:244-256.
51. Voorn, P., Roest, G., and Groenewegen, H.J. (1987) Increase of enkephalin and decrease of substance P immunoreactivity in the dorsal and ventral striatum of the rat after midbrain 6-hydroxydopamine lesions. Brain Res., 412:391-396.
52. Voorn, P., Docter, G.J., Jongen-Rêlo, A.L., and Jonker, A.J. (1994) Rostrocaudal subregional differences in the response of enkephalin, dynorphin and substance P synthesis in rat nucleus accumbens to dopamine depletion. Eur. J. Neurosci., 6:486-496.
53. Yoshikawa, K., Williams, C., and Sabol, S.L. (1984) Rat brain preproenkephalin mRNA. cDNA cloning, primary structure, and distribution in the central nervous system. J. Biol. Chem., 259:14301-14308.
54. Young, W.S. (1990) In situ hybridization histochemistry. In: Methods for the Study of Neuronal Microcircuits and Synaptic Interactions: Handbook of Chemical Neuroanatomy, Vol. 8. F.G. Wouterlood, and A.N. Van den Pol, eds. Elsevier, Amsterdam, pp. 481-512.
55. Young, W.S., Bonner, T.I., and Brann, M.R. (1986) Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc. Natl. Acad. Sci. U.S.A., 83:9327-9831.